Skip to content

About
R&D
- R&D
- PENAO
Core Businesses
Products
Investors
News
Contact
English

Search this website

Daily Archives: 2018-12-29

Home>
2018>
December>
29

Read more about the article New Year Address of Beroni Group

New Year Address of Beroni Group

Post author:admin
Post published:2018-12-29
Post category:2018

Continue ReadingNew Year Address of Beroni Group

Search Article

Search this website

Arrange by Year

2017 (10)
2018 (24)
2019 (25)
2020 (17)
2021 (11)
2022 (8)
2023 (6)
2024 (1)

What’s New

New Year Greetings from Mr. Jacky Zhang！
Wish You Happy New Year！
Beroni Pharmaceutical has received approval from the Environmental Impact Report Form of the Zhuhai Ecological Environment Bureau
Beroni Group was Invited to Attend the 4th World-Class Enterprises R&D and Innovation Management Forum
Successful Conclusion to the Conference of FET

Beroni Group is an international biotechnological company listed on the National Stock Exchange (Australia) and traded on the OTC markets in the USA with business presence in Australia, China, Japan and the USA. It currently has four core businesses – research and development of new drugs and clinical trial, immune cell therapy including gene detection and diagnosis, immunotherapy for cancer treatment, diagnosis of infectious diseases and e-commerce based on the Internet sales of pharmaceutical, healthcare and cosmetic products.

About

About Beroni
Our History
Board of Directors
Management Team
Vision, Mission, and Values

Core Businesses

Cell Therapy
Anti-Cancer Drugs
Infectious Diseases
E-Commerce

Products

By Beroni China
By Beroni Japan
By Beroni USA

Copyrights© Beroni Group 2019 | All rights reserved |

website by chase e-Design